Cyclophosphamide

LE WE PMID CA

Cyclophosphamide

616

Cyclophosphamid

Acrolein

Aldehyde dehydrogenase

Angiostatin

Autoimmunity

Bone marrow transplantation

CD25

CTLA4

Cyclophosphamide

Eye and Orbita (Uveitis)

Graft vs host disease

Lung (Toxicology)

Multiple sclerosis

Pharmacogenomics

Regulatory T cell

Systemic lupus erythematosus

TNP470

Tolerance (Immunology)

Vaccine (Oncology)

2004 1	Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis? [15683089] Neth J Med 62(10): 347-52 (2004)
2004 2	Angiogenesis inhibition by angiostatin, endostatin and TNP-470 prevents cyclophosphamide induced cystitis. [15302998] Angiogenesis 7(1): 69-73 (2004)
1997 3	Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. [9306871] Ann Rheum Dis 56(8): 481-7 (1997)
2000 4	The molecular effects of acrolein. [10966506] Toxicol Sci 57(1): 6-15 (2000)
2004 5	Cyclophosphamide for severe lupus nephritis: where are we now? [15593210] Arthritis Rheum 50(12): 3748-50 (2004)
2010 6	Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. [20039416] Arthritis Rheum 62(1): 9-21 (2010)
2009 7	How did cyclophosphamide become the drug of choice for lupus nephritis? [19056783] Nephrol Dial Transplant 24(2): 381-4 (2009)
2002 8	High dose cyclophosphamide treatment for autoimmune disorders. [12806171] ScientificWorldJournal 2(-): 1808-15 (2002)
2005 9	Clinical significance of cyclophosphamide-induced cardiotoxicity. [15750266] Intern Med 44(2): 89-90 (2005)
2003 10	Cyclophosphamide-induced late-onset lung disease. [12583625] Intern Med 42(1): 82-7 (2003)
2008 11	Malignancies and cyclophosphamide exposure in Wegener's granulomatosis. [18176988] J Rheumatol 35(1): 11-3 (2008)
2011 12	Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models. [21394107] Cancer Gene Ther 18(6): 407-18 (2011)
2009 13	Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms. [21180630] Ther Adv Neurol Disord 2(6): 50-61 (2009)
2011 14	Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care? [20689319] Nephron Clin Pract 117(1): c8-14 (2011)
2009 15	Cyclophosphamide therapy in pediatric multiple sclerosis. [19439723] Neurology 72(24): 2076-82 (2009)
2010 16	Cyclophosphamide for ocular inflammatory diseases. [19969366] Ophthalmology 117(2): 356-65 (2010)
2009 17	Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy. [19958089] Pharmacogenomics 10(12): 1897-903 (2009)
2010 18	High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. [20066512] Immunol Res 47(1-3): 65-77 (2010)
2008 19	Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages. [18958751] Autoimmunity 41(8): 596-600 (2008)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cyclophosphamide.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cyclophosphamide.php on line 92